TLR4 and cancer: A recent study showed that NETs can directly alter the metabolic program of cancer cells by releasing NE and activating the TLR4–P38–PGC-1α pathway to increase mitochondrial biogenesis, thereby promoting cancer cell proliferation and tumor growth [188].